Does cellular iron dysregulation play a causative role in Parkinson’s disease?
Authors:
- Julie AndersenJAJulie Andersen
- 1 July 2004
- journal article
- review article
- Published by Elsevier in Ageing Research Reviews
- Vol. 3 (3) , 327-343
Abstract
No abstract availableKeywords
This publication has 92 references indexed in Scilit:
- Oxidative stress in Parkinson's diseaseAnnals of Neurology, 2003
- Metal-triggered Structural Transformations, Aggregation, and Fibrillation of Human α-SynucleinJournal of Biological Chemistry, 2001
- IRON REGULATORY PROTEINS AND THE MOLECULAR CONTROL OF MAMMALIAN IRON METABOLISMAnnual Review of Nutrition, 2000
- The genetics of Parkinson's diseaseCurrent Opinion in Genetics & Development, 2000
- AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's diseaseNature Genetics, 1998
- Mutation in the α-Synuclein Gene Identified in Families with Parkinson's DiseaseScience, 1997
- Excessive iron accumulation in the brain: A possible potential risk of neurodegeneration in Parkinson's diseaseJournal of Neural Transmission, 1997
- Desferrioxamine and vitamin E protect against iron and MPTP-induced neurodegeneration in miceJournal of Neural Transmission, 1997
- Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brainJournal of Neural Transmission, 1988
- Original Papers: ON THE OCCURRENCE OF ABNORMAL DEPOSITS OF IRON IN THE BRAIN IN PARKINSONISM WITH SPECIAL REFERENCE TO ITS LOCALISATION.Journal of Neurology, Neurosurgery & Psychiatry, 1924